Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Antiviral
Sort By
Newest First
1 / 1
1 / 1
M&A
Novo Holdings Portfolio Company ReViral to be Acquired by Pfizer
Novo Holdings A/S
PR-M04-22-05
Apr 07, 2022
COVID-19 Antiviral
Model Medicines' Oral Anti-COVID-19 Drug Candidate MDL-001 Found to Significantly Reduce Viral Load in Lungs; Accepted into NIH's Antiviral Program for Pandemics (APP)
Model Medicines
PR-M02-22-05
Feb 08, 2022
COVID-19 Research
MU Study Identifies Mutations Specific to Omicron Variant
University of Missouri
PR-M01-22-17
Jan 25, 2022
Nice Insight Overview
Drug Approval Trends: Significant Acceleration in Recent Years
Nigel Walker
Nice Insight
PAP-Q2-20-NI-001
Jul 01, 2020
COVID-19
Q: What is your perspective on how the pharma industry has responded to the COVID-19 pandemic? What lessons have been learned?
Pharma's Almanac
PAP-Q2-20-RT-001
Jul 01, 2020
BioMed X Institute Launches Rapid Antiviral Response Platform to Prevent Future Pandemics
BioMed X
PR-M05-20-NI-037
May 26, 2020
Licensing
Gilead Licenses Antiviral Candidates from Novartis
Nice Insight
PAO-M08-19-NI-019
Aug 15, 2019
Antiviral
Progress on New Antiviral Drugs at Chimerix
Emilie Branch
Pharma's Almanac
PAO-M06-18-NI-019
Jun 21, 2018
